Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy in combination with pembrolizumab for adults with various solid tumors that have failed …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
Expanded access program for Ulixertinib (BVD-523) in patients with advanced MAPK pathway-altered malignancies across multiple tumor types. T…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
Immune checkpoint inhibitor–related gonadal toxicity in premenopausal women and men with melanoma is described. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
A clinical trial evaluating the effects of anti-PD1 adjuvant checkpoint blockade immunotherapy on atypical/dysplastic nevi in melanoma patie…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study [NA]
This update reports completion of the INSPIRE-AYA clinical trial, an interactive survivorship program aimed at improving healthcare resource…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma [Phase 3]
A Phase 3 trial evaluating MB11 against Opdivo (nivolumab) in previously untreated advanced melanoma, assessing pharmacokinetics, efficacy, …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization [Phase 1]
Phase 1 trial evaluating an RNA-lipid particle vaccine intended to sensitize tumors to anti-PD-1 therapy in patients with melanoma and soft …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma [Phase 2]
Phase 2 neoadjuvant trial of pembrolizumab in patients with stage IIb/c melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery [Phase 1]
A Phase 1 clinical trial update evaluating the combination of pembrolizumab and ibrutinib for unresectable stage III–IV melanoma, sponsored …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
This entry describes an ongoing University of Wisconsin–Madison clinical trial evaluating whether early FDG PET/CT imaging and circulating t…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
This clinical trial update describes the collection of tissue and blood from patients with benign and malignant tumors of the soft tissue an…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases [Phase 2]
Phase II trial evaluating nivolumab in combination with relatlimab for active melanoma brain metastases is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors [Phase 2]
ClinicalTrials.gov update for QUILT-3.055, a Phase 2 study of combination immunotherapies in patients who previously received immune checkpo…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Clinical Study of T3011 in Subjects With Advanced Melanoma [Phase 1, Phase 2]
A clinical trial update for a Phase 1/2 study of T3011 in patients with melanoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma [Phase 3]
A Phase 3 study evaluating Amgen's ABP-206 versus Opdivo (nivolumab) in unresectable or metastatic melanoma. The trial is currently active b…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
A clinical trial update describes long-term safety outcomes in patients previously treated with RP1, RP2, or RP3 and is currently recruiting…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma [Phase 1, Phase 2]
This update covers the Phase 1/2 study of the investigational agent NUC-7738 in patients with advanced solid tumors and lymphoma, focusing o…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 study to assess the long-term health of adults who previously participated in a melanoma t…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors [Phase 1]
A Phase 1 clinical trial from AgonOx is evaluating cancer-specific CD8+ TIL-based adoptive cell therapy in adults with solid tumors, includi…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies
A clinical trial update examining how immune checkpoint inhibitors and other immunotherapies may drive tumor evolution through treatment-ind…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma [Phase 2]
Phase 2 clinical trial evaluating a PD-1 antibody therapy in combination with infliximab for metastatic melanoma.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Integrated Molecular Profiling in Advanced Cancers Trial
An ongoing trial, Integrated Molecular Profiling in Advanced Cancers, sponsored by University Health Network in Toronto, investigates using …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors [NA]
This entry reports a recruiting clinical trial evaluating urolithin A in patients with previously untreated solid tumors receiving immune ch…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
A clinical trial funded by Elephas is exploring a biomarker-based method to predict response to immunotherapy using live tumor biopsies; the…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating in situ immunomodulation using CDX-301, CDX-1140, and Poly-ICLC with radiation therapy in patients with unresecta…